(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 4.63% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Thermo Fisher Scientific's revenue in 2025 is $42,879,000,000.On average, 8 Wall Street analysts forecast TMO's revenue for 2025 to be $16,497,806,538,048, with the lowest TMO revenue forecast at $16,358,837,477,263, and the highest TMO revenue forecast at $16,577,233,598,262. On average, 8 Wall Street analysts forecast TMO's revenue for 2026 to be $17,593,718,581,819, with the lowest TMO revenue forecast at $17,158,593,079,724, and the highest TMO revenue forecast at $18,019,880,358,230.
In 2027, TMO is forecast to generate $19,088,045,973,848 in revenue, with the lowest revenue forecast at $18,848,990,653,262 and the highest revenue forecast at $19,268,614,870,650.